Vildagliptin Unknown Status Phase 4 Trials for Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01426737The Swiss Glucose Variability Study
NCT01565096Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy